Metabolic testing in mitochondrial disease

Seminars in Neurology

Volumn 21, Issue 3, 2001, Pages 303-308

  Dougherty, F E ^a  

^a Horizon Molecular Medicine   (United States)

Author keywords

Amino acids; Carnitine; Lactate; Metabolic screening; Metabolic testing; Mitochondrial disease; Organic acids; Pyruvate

Indexed keywords

AMINO ACID; CARBOXYLIC ACID; CARNITINE; LACTIC ACID; MITOCHONDRIAL DNA; PYRUVIC ACID;

DIAGNOSTIC TEST; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ASSAY; HUMAN; METABOLIC DISORDER; MUSCLE BIOPSY; OXIDATIVE PHOSPHORYLATION; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; SCREENING;

EDUCATION, MEDICAL, CONTINUING; HUMANS; MASS SCREENING; MITOCHONDRIAL DISEASES;

EID: 0034770541     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-17947     Document Type: Review

References (27)

1. Mitochondrial genes and disease
2. Maternal genes: Mitochondrial diseases
3. Mitochondrial DNA mutations and neuromuscular disease
4. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region
5. Retinitis pigmentosa: External ophthalmoplegia and complete heart block
6. Mitochondrial myopathy, lactic acidosis, stroke-like episodes: A distinctive clinical syndrome
7. Myoclonus epilepsy associated with ragged red fibers (mitochondrial abnormalities): Disease entity or a syndrome? Light and electron microscopy studies of two cases and a review of the literature
8. Clinical aspects of mitochondrial disorders
9. The 8993 mtDNA mutation: Heteroplasmy and clinical presentation in three families
10. Problems with the biochemical diagnosis in mitochondrial (enchephalo-) myopathies
11. Marked reduction in CSF lactate and pyruvate levels after CoQ therapy in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS)
12. Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders
13. Carnitine: Metabolism and functions
14. Carnitine deficiency, organic acidemias and Reye's syndrome
15. Carnitine biosynthesis in Neurospora crassa: Enzymatic conversion of lysine to alpha-N-trimethyllysine
16. Carnitine deficiency in cirrhosis
17. Metabolic myopathies
18. Plasma carnitine insufficiency and effectiveness of L-carnitine therapy in patients with mitochondrial myopathy
19. CPEO and carnitine deficiency overlapping in MELAS syndrome
20. Secondary carnitine deficiency and impaired docosahexaenoic (22:6n-3) acid deficiency: A common denominator in the pathophysiology of diseases of oxidative phosphorylation and beta-oxidation
21. Renal amino acid transport in adults with oxidative phosphorylation diseases
22. Tiglyglycine excreted in urine in disorders of isoleucine metabolism and the respiratory chain measured by stable isotope dilution GC-MS
23. Kearns-Sayre syndrome presenting as 2-oxoadipic aciduria
24. Clinical presentation of patients with mitochondrial respiratory chain defects in NADH coenzyme Q reductase and cyrochrome oxidase: Clues to the pathogenesis of Leigh disease
25. Abnormal kinetic behaviour of cyrochrome oxidase in a case of Leigh's disease
26. Evaluation procedures for assaying oxidative phosphorylation enzyme activities in mitochondrial myopathy muscle biopsies
27. Presymptomatic diagnosis of hypoparathyroidism in patients with mitochondrial disease